3SBio Inc. To Hold 2011 Annual General Meeting On September 20, 2011
SHENYANG, China, Aug. 20, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the annual general meeting of shareholders of 3SBio Inc. will be held on September 20, 2011 at 10:00 a.m., Shenyang time, at our executive office, 15/A-D, Huaxin International Tower, No. 219, Qingnian Ave., Shenhe District, Shenyang 110016, People's Republic of China. The shareholder record date is August 15, 2011.
3SBio has filed its annual report on Form 20-F with the audited financial statements for the fiscal year ended December 31, 20010, with the U.S. Securities and Exchange Commission (the "SEC"). 3SBio's annual report on Form 20-F can be accessed on the Investors section of the Company's website at http://www.3SBio.com, as well as on the SEC's website at http://www.sec.gov. The materials related to the annual general meeting, including the notice of meeting, the proxy statement, and the voting card may also be accessed and downloaded at the Investors section of the Company website. Shareholders may request a hard copy of the above documents free of charge by contacting ir@3SBio.com.
About 3SBio Inc.
3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 700 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see www.3SBio.com for more information.Investor Contacts Bo TanChief Financial Officer3SBio Inc.Tel: + 86 24 2581-1820 ir@3SBio.com Tom FolinsbeeDirector of Investor Relations3SBio Inc. Tel: + 852 8191-6991 ir@3SBio.com SOURCE 3SBio Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts